Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Phenylbutyrate in Presymptomatic SMA Infants
NCT00528268Phase 2Completed
- Sponsor
- University of Utah
- Start
- Jul 2007
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium phenylbutyrate in spinal muscular atrophy (SMA), sponsored by University of Utah. Started Jul 2007; status: completed.
02
Drugs
sodium phenylbutyrate
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on NCT00528268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528268.